SerImmune

About SerImmune

SerImmune reveals the compositions of functional immune repertoires, creating new opportunities for therapeutic and diagnostic development. SerImmune maps the distinct antibodies within a repertoire to antigens associated with infections, allergens, microbiome organisms, autoimmune diseases, and cancers.
YEAR FOUNDED:
2014
LEADERSHIP:
CEO: Patrick Daugherty
TECHNOLOGY
Please click here for SerImmune's technology.